by Cells4Life Middle East | Dec 21, 2013 | Stem Cell Therapy
The US Food and Drug Administration (FDA) has approved a groundbreaking medical strategy– a new stem cell clinical trial for multiple sclerosis (MS). Multiple Sclerosis is a chronic disease that attacks the central nervous system (the spinal cord,...
by Cells4Life Middle East | Nov 3, 2013 | Stem Cell Therapy
Matthew Farrow, then a 5 year old boy with Fanconi anemia, received the world’s first cord blood transplant. The pioneering medical event was an international effort: Matthew came from North Carolina USA, his donor was his newborn baby sister, the American...
by Cells4Life Middle East | Aug 21, 2013 | Stem Cell Therapy
A Phase 1 stem cell clinical trial for Multiple Sclerosis (MS) will be conducted by the researchers at Tisch Multiple Sclerosis Research Center New York. MS is a chronic human autoimmune disease that leads to myelin damage and neurodegeneration and impacts...
by Cells4Life Middle East | Jun 30, 2013 | Stem Cell Therapy
When injured or invaded by disease, our bodies have the innate response to heal and defend. What if it was possible to harness the power of the body to heal and then accelerate it in a clinically relevant way? What if we could help the body to heal itself better? The...
by Cells4Life Middle East | Jun 22, 2013 | Cord Blood Banking
The National Health Service (NHS) Cord Blood Bank in the United Kingdom has adopted Cells4Life Gold service method of cord blood volume reduction using Thermogenesis AXP System. The NHS manages six umbilical cord blood facilities and a cord blood...
